Filtros : "SOGAYAR, MARI CLEIDE" "Melanoma Research" Removidos: "Filologia e Língua Portuguesa" "PARTE DE MONOGRAFIA/LIVRO" "MP" Limpar

Filtros



Limitar por data


  • Fonte: Melanoma Research. Unidade: IQ

    Assuntos: MELANOMA, EXPRESSÃO GÊNICA, METALOPROTEINASES

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      JACOMASSO, Thiago et al. The alternatively spliced RECK transcript variant 3 is a predictor of poor survival for melanoma patients being upregulated in aggressive cell lines and modulating MMP gene expression in vitro. Melanoma Research, v. 30, n. 3, p. 223-234, 2020Tradução . . Disponível em: https://doi.org/10.1097/CMR.0000000000000650. Acesso em: 09 ago. 2024.
    • APA

      Jacomasso, T., Ribas, H. T., Lima, M. T., Konig, M. S., Trindade, E. da S., Martinez, G. R., et al. (2020). The alternatively spliced RECK transcript variant 3 is a predictor of poor survival for melanoma patients being upregulated in aggressive cell lines and modulating MMP gene expression in vitro. Melanoma Research, 30( 3), 223-234. doi:10.1097/CMR.0000000000000650
    • NLM

      Jacomasso T, Ribas HT, Lima MT, Konig MS, Trindade E da S, Martinez GR, Sogayar MC, Winnischofer SMB. The alternatively spliced RECK transcript variant 3 is a predictor of poor survival for melanoma patients being upregulated in aggressive cell lines and modulating MMP gene expression in vitro [Internet]. Melanoma Research. 2020 ; 30( 3): 223-234.[citado 2024 ago. 09 ] Available from: https://doi.org/10.1097/CMR.0000000000000650
    • Vancouver

      Jacomasso T, Ribas HT, Lima MT, Konig MS, Trindade E da S, Martinez GR, Sogayar MC, Winnischofer SMB. The alternatively spliced RECK transcript variant 3 is a predictor of poor survival for melanoma patients being upregulated in aggressive cell lines and modulating MMP gene expression in vitro [Internet]. Melanoma Research. 2020 ; 30( 3): 223-234.[citado 2024 ago. 09 ] Available from: https://doi.org/10.1097/CMR.0000000000000650
  • Fonte: Melanoma Research. Unidade: IQ

    Assuntos: MELANOMA, METALOPROTEINASES

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      JACOMASSO, Thiago et al. Downregulation of reversion-inducing cysteine-rich protein with Kazal motifs in malignant melanoma: inverse correlation with membrane-type 1-matrix metalloproteinase and tissue inhibitor of metalloproteinase 2. Melanoma Research, v. 24, n. 1, p. 32-39, 2014Tradução . . Disponível em: https://doi.org/10.1097/CMR.0000000000000039. Acesso em: 09 ago. 2024.
    • APA

      Jacomasso, T., Trombetta-Lima, M., Sogayar, M. C., & Winnischofer, S. M. B. (2014). Downregulation of reversion-inducing cysteine-rich protein with Kazal motifs in malignant melanoma: inverse correlation with membrane-type 1-matrix metalloproteinase and tissue inhibitor of metalloproteinase 2. Melanoma Research, 24( 1), 32-39. doi:10.1097/CMR.0000000000000039
    • NLM

      Jacomasso T, Trombetta-Lima M, Sogayar MC, Winnischofer SMB. Downregulation of reversion-inducing cysteine-rich protein with Kazal motifs in malignant melanoma: inverse correlation with membrane-type 1-matrix metalloproteinase and tissue inhibitor of metalloproteinase 2 [Internet]. Melanoma Research. 2014 ; 24( 1): 32-39.[citado 2024 ago. 09 ] Available from: https://doi.org/10.1097/CMR.0000000000000039
    • Vancouver

      Jacomasso T, Trombetta-Lima M, Sogayar MC, Winnischofer SMB. Downregulation of reversion-inducing cysteine-rich protein with Kazal motifs in malignant melanoma: inverse correlation with membrane-type 1-matrix metalloproteinase and tissue inhibitor of metalloproteinase 2 [Internet]. Melanoma Research. 2014 ; 24( 1): 32-39.[citado 2024 ago. 09 ] Available from: https://doi.org/10.1097/CMR.0000000000000039

Biblioteca Digital de Produção Intelectual da Universidade de São Paulo     2012 - 2024